MX164198B - Una composicion farmaceutica - Google Patents

Una composicion farmaceutica

Info

Publication number
MX164198B
MX164198B MX8192A MX819285A MX164198B MX 164198 B MX164198 B MX 164198B MX 8192 A MX8192 A MX 8192A MX 819285 A MX819285 A MX 819285A MX 164198 B MX164198 B MX 164198B
Authority
MX
Mexico
Prior art keywords
sub
alkyl
hydrogen
phenyl
pharmaceutical composition
Prior art date
Application number
MX8192A
Other languages
English (en)
Inventor
Guy Nadler
Jean-Bernard Le Polles
Marie-Noelle Legave
Original Assignee
Sobio Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sobio Lab filed Critical Sobio Lab
Publication of MX164198B publication Critical patent/MX164198B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Indole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MX8192A 1984-06-30 1985-06-28 Una composicion farmaceutica MX164198B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848416724A GB8416724D0 (en) 1984-06-30 1984-06-30 Active compounds

Publications (1)

Publication Number Publication Date
MX164198B true MX164198B (es) 1992-07-23

Family

ID=10563258

Family Applications (1)

Application Number Title Priority Date Filing Date
MX8192A MX164198B (es) 1984-06-30 1985-06-28 Una composicion farmaceutica

Country Status (14)

Country Link
US (1) US4853391A (es)
EP (1) EP0167901B1 (es)
JP (1) JPH0699430B2 (es)
AT (1) ATE51623T1 (es)
AU (1) AU583520B2 (es)
CA (1) CA1296730C (es)
DE (1) DE3576956D1 (es)
ES (4) ES8701157A1 (es)
GB (1) GB8416724D0 (es)
GR (1) GR851602B (es)
IE (1) IE58102B1 (es)
MX (1) MX164198B (es)
NZ (1) NZ212588A (es)
ZA (1) ZA854902B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3677101D1 (de) 1985-06-28 1991-02-28 Beecham Wuelfing Gmbh & Co Kg Tetrahydropyrido-(1,2-a)-indolderivate, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
US4624954A (en) * 1985-12-20 1986-11-25 American Home Products Corporation 6,7,8,9-tetrahydro-10-methylpyrido[1,2-a]indol-9-amines and derivatives thereof, useful for the treatment of cognitive impairments
EP0252643A1 (en) 1986-07-01 1988-01-13 BEECHAM - WUELFING GmbH & Co. KG Pyrido[1,2-a]indole derivatives, process for their preparation and pharmaceutical compounds containing them
CA1329597C (en) * 1986-12-22 1994-05-17 Dagmar Hoeltje Derivatives of tetrahydropyrido[1,2-a]indole
US5290785A (en) * 1988-09-27 1994-03-01 Fujisawa Pharmaceutical Co., Ltd. Therapeutic agent for ischemic diseases
GB9819035D0 (en) * 1998-09-01 1998-10-28 Cerebrus Res Ltd Chemical compounds VII
ATE319683T1 (de) * 1998-12-11 2006-03-15 Univ Virginia Commonwealth Selektive 5-ht 6-rezeptor-liganden
EP1693366A1 (en) * 1998-12-11 2006-08-23 Virginia Commonwealth University Selective 5-HT 6 receptor ligands
EP1132389A1 (en) 2000-03-06 2001-09-12 Vernalis Research Limited New aza-indolyl derivatives for the treatment of obesity
EP1554572B1 (en) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US7608626B2 (en) 2004-11-01 2009-10-27 Wyeth Substituted indolizines and derivatives as CNS agents
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
EP2063905B1 (en) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
NZ616673A (en) 2009-02-20 2014-08-29 To Bbb Holding B V Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1550496A (en) * 1976-12-31 1979-08-15 Logeais Labor Jacques 1,2,3,3a4,5-hexahydro-canthine derivatives a process for their preparation and their therapeutic applications
US4328343A (en) * 1978-03-13 1982-05-04 The United States Of America As Represented By The Department Of Health And Human Services Cobalt-catalyzed one-step synthesis of annulated pyridines
EP0036269A1 (en) * 1980-03-15 1981-09-23 Beecham Group Plc Substituted benzamides
US4595688A (en) * 1983-06-23 1986-06-17 Mcneilab, Inc. Hexahydropyrrolo[2,1-a]isoquinoline derivatives and antidepressant use thereof
DE3677101D1 (de) * 1985-06-28 1991-02-28 Beecham Wuelfing Gmbh & Co Kg Tetrahydropyrido-(1,2-a)-indolderivate, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
US4624954A (en) * 1985-12-20 1986-11-25 American Home Products Corporation 6,7,8,9-tetrahydro-10-methylpyrido[1,2-a]indol-9-amines and derivatives thereof, useful for the treatment of cognitive impairments

Also Published As

Publication number Publication date
DE3576956D1 (de) 1990-05-10
JPH0699430B2 (ja) 1994-12-07
GB8416724D0 (en) 1984-08-01
JPS6130587A (ja) 1986-02-12
AU4424385A (en) 1986-01-02
IE58102B1 (en) 1993-06-30
IE851633L (en) 1985-12-30
EP0167901B1 (en) 1990-04-04
AU583520B2 (en) 1989-05-04
ES552653A0 (es) 1987-03-16
ES8704164A1 (es) 1987-03-16
ZA854902B (en) 1986-05-28
ES8701157A1 (es) 1986-11-16
EP0167901A3 (en) 1987-05-13
ES8704166A1 (es) 1987-03-16
GR851602B (es) 1985-11-25
ES8704165A1 (es) 1987-03-16
ES544729A0 (es) 1986-11-16
EP0167901A2 (en) 1986-01-15
CA1296730C (en) 1992-03-03
US4853391A (en) 1989-08-01
NZ212588A (en) 1989-01-06
ES552655A0 (es) 1987-03-16
ATE51623T1 (de) 1990-04-15
ES552654A0 (es) 1987-03-16

Similar Documents

Publication Publication Date Title
MX164198B (es) Una composicion farmaceutica
DE3650357T2 (de) Tricyclische aromatische Verbindungen.
FI891176A (fi) Peptidfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
MX154758A (es) Procedimiento para preparacion de derivados de succinimida
KR930006027A (ko) 엔케팔리나제 및 안지오텐신 전환 효소(ace)의 억제제로서 유용한 2-치환 인단-2-메르캅토아세틸아미드 유도체
DE68925223D1 (de) 3-Alkenyl-1-azabicyclo(3.2.0)hept-2-en-2-carbonsäure-Verbindungen
TR200200099T2 (tr) Th2 farklılaşma inhibitörleri
KR920008046A (ko) 티에노이미다졸 유도체, 그의 제조방법 및 용도
IL70477A0 (en) Dihydropyridines and pharmaceutical compositions containing them
ATE53025T1 (de) 7-(2-(dialkylamino)ethly>-4-hydroxy-1,3benzimidazol-2-one.
AU5296199A (en) Antibacterial agents
RU95110868A (ru) Новые конденсированные производные тиазола, способ его получения и его фармацевтическая композиция
GB1437799A (en) Benzimidazolinone compounds
ES553358A0 (es) Un procedimiento para preparar compuestos heterociclicos fusionados con benceno